v3.26.1
Condensed Consolidated Statements of Shareholders’ Equity / (Deficit) - USD ($)
$ in Thousands
Total
ADDITIONAL PAID-IN CAPITAL
ACCUMULATED OTHER COMPREHENSIVE (LOSS)/INCOME
ACCUMULATED DEFICIT
Ordinary shares
ORDINARY SHARES
Beginning balance (in shares) at Dec. 31, 2024         68,552,215
Beginning balance at Dec. 31, 2024 $ 154,695 $ 704,919 $ (16,194) $ (534,732) $ 702
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of ordinary shares, net of issuance costs (in shares)         24,014,728
Issuance of ordinary shares, net of issuance costs 54,816 54,583     $ 233
Exercise of share options (in shares)         164,422
Exercise of share options 2       $ 2
Issuance of ordinary shares to settle vested restricted stock units (in shares)         116,961
Issuance of ordinary shares to settle vested restricted stock units 0 (1)     $ 1
Share-based compensation expense 3,935 3,935      
Unrealized loss on foreign currency translation (117)   (117)    
Net income (loss) (17,864)     (17,864)  
Ending balance (in shares) at Mar. 31, 2025         92,848,326
Ending balance at Mar. 31, 2025 $ 195,467 763,436 (16,311) (552,596) $ 938
Beginning balance (in shares) at Dec. 31, 2025 96,085,785       96,085,785
Beginning balance at Dec. 31, 2025 $ (52,848) 783,562 (14,789) (822,594) $ 973
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of ordinary shares, net of issuance costs (in shares)         17,500,000
Issuance of ordinary shares, net of issuance costs 131,286 131,097     $ 189
Exercise of share options (in shares)         6,333
Exercise of share options 24 23     $ 1
Issuance of ordinary shares to settle vested restricted stock units (in shares)         170,558
Issuance of ordinary shares to settle vested restricted stock units 0 (2)     $ 2
Issuance of ordinary shares to settle warrant exercised (in shares)         21,160,619
Issuance of ordinary shares to settle warrant exercised 154,133 153,905     $ 228
Share-based compensation expense 2,896 2,896      
Unrealized loss on foreign currency translation (6)   (6)    
Net income (loss) $ 91,202     91,202  
Ending balance (in shares) at Mar. 31, 2026 134,923,295       134,923,295
Ending balance at Mar. 31, 2026 $ 326,687 $ 1,071,481 $ (14,795) $ (731,392) $ 1,393